Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles - PubMed (original) (raw)
. 2008 May;19(5):1009-16.
doi: 10.1021/bc700421u. Epub 2008 Apr 5.
Affiliations
- PMID: 18393455
- DOI: 10.1021/bc700421u
Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles
Yanli Liu et al. Bioconjug Chem. 2008 May.
Abstract
The present study investigates the applicability of nanoparticle delivery vectors for two-stage targeting that involves both cell entry by endocytosis and nuclear targeting using viral peptide signals. A nanoparticle vector consists of four components: a carrier nanoparticle, a stabilizer, targeting peptides, and a therapeutic cargo. Extensive study of bovine serum albumin (BSA)-peptide stabilized nanoparticle conjugates demonstrated limitations of these systems due to colloidal instability when oligonucleotides and multiple peptides were attached to the BSA protein. We found that the widely used protein streptavidin (SA) was an appropriate alternative to BSA for cell-targeting experiments. Targeting peptides and gene splicing oligonucleotides were attached to SA-nanoparticles using biotin labels. The present study uses a gene-splicing assay as a test for oligonucleotide delivery to the cell nucleus. Successful modification of gene splicing by an antisense oligonucleotide indicates that the latter must have crossed the plasma membrane, entered the nucleus, found the target sequence in the newly transcribed pre-mRNA, and hybridized to it in the spliceosome strongly enough to displace the splicing factors designed to interact with the target sequence. Targeting nanoparticles that carry gene-splicing oligonucleotides were compared with a control experiment that used lipofectamine (LF). While enhanced activity was observed in the control experiment, in the presence of LF, no gene splicing was observed for the nanoparticle targeting vectors without LF. We conclude that sequestration of cargo from the harsh conditions of the endosome is a desirable strategy for cell-targeting nanoparticles.
Similar articles
- Multifunctional gold nanoparticle-peptide complexes for nuclear targeting.
Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF, Franzen S, Feldheim DL. Tkachenko AG, et al. J Am Chem Soc. 2003 Apr 23;125(16):4700-1. doi: 10.1021/ja0296935. J Am Chem Soc. 2003. PMID: 12696875 - Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S, Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B. Abes S, et al. J Control Release. 2006 Dec 1;116(3):304-13. doi: 10.1016/j.jconrel.2006.09.011. Epub 2006 Sep 30. J Control Release. 2006. PMID: 17097177 - Antisense effects in the cell nucleus: modification of splicing.
Kole R, Sazani P. Kole R, et al. Curr Opin Mol Ther. 2001 Jun;3(3):229-34. Curr Opin Mol Ther. 2001. PMID: 11497345 Review. - Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains.
Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, Shipton MK, Franzen S, Feldheim DL. Tkachenko AG, et al. Bioconjug Chem. 2004 May-Jun;15(3):482-90. doi: 10.1021/bc034189q. Bioconjug Chem. 2004. PMID: 15149175 - Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
Zhao X, Pan F, Holt CM, Lewis AL, Lu JR. Zhao X, et al. Expert Opin Drug Deliv. 2009 Jul;6(7):673-86. doi: 10.1517/17425240902992894. Expert Opin Drug Deliv. 2009. PMID: 19552611 Review.
Cited by
- Biological barriers to therapy with antisense and siRNA oligonucleotides.
Juliano R, Bauman J, Kang H, Ming X. Juliano R, et al. Mol Pharm. 2009 May-Jun;6(3):686-95. doi: 10.1021/mp900093r. Mol Pharm. 2009. PMID: 19397332 Free PMC article. Review. - Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles.
Prigodich AE, Alhasan AH, Mirkin CA. Prigodich AE, et al. J Am Chem Soc. 2011 Feb 23;133(7):2120-3. doi: 10.1021/ja110833r. Epub 2011 Jan 26. J Am Chem Soc. 2011. PMID: 21268581 Free PMC article. - Monolayer coated gold nanoparticles for delivery applications.
Rana S, Bajaj A, Mout R, Rotello VM. Rana S, et al. Adv Drug Deliv Rev. 2012 Feb;64(2):200-16. doi: 10.1016/j.addr.2011.08.006. Epub 2011 Sep 6. Adv Drug Deliv Rev. 2012. PMID: 21925556 Free PMC article. Review. - Investigation of Sub-100 nm Gold Nanoparticles for Laser-Induced Thermotherapy of Cancer.
Leung JP, Wu S, Chou KC, Signorell R. Leung JP, et al. Nanomaterials (Basel). 2013 Jan 31;3(1):86-106. doi: 10.3390/nano3010086. Nanomaterials (Basel). 2013. PMID: 28348323 Free PMC article. - Rational design of gold nanocarrier for the delivery of JAG-1 peptide.
Matea CT, Mocan T, Tabaran F, Iancu C, Mocan LC. Matea CT, et al. J Nanobiotechnology. 2015 Jun 16;13:41. doi: 10.1186/s12951-015-0100-x. J Nanobiotechnology. 2015. PMID: 26077042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources